Report Detail

Request for Sample of this report

Pharma & Healthcare Global Guaifenesin (API) Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • RnM2952610
    • |
  • 15 February, 2019
    • |
  • Global
    • |
  • 118 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Pharma & Healthcare

Guaifenesin is used to relieve chest congestion. Guaifenesin may help control symptoms but does not treat the cause of symptoms or speed recovery. Guaifenesin is in a class of medications called expectorants. It works by thinning the mucus in the air passages to make it easier to cough up the mucus and clear the airways.

Scope of the Report:
The global average price of Guaifenesin (API) is in the decreasing trend, from 8.62 USD/Kg in 2012 to 7.61 USD/Kg in 2016. With the situation of global economy, prices will be in decreasing trend in the following five years.
The classification of Guaifenesin (API) includes 98%-99% Guaifenesin and >99% Guaifenesin, and the proportion of >99% Guaifenesin is about 74%, and the proportion is in increasing trend from 2012 to 2016.
Guaifenesin (API) is mainly used in Pharmaceuticals industry. The proportion of Guaifenesin (API) used in Pharmaceuticals industry is about 92%.
The worldwide market for Guaifenesin (API) is expected to grow at a CAGR of roughly 0.6% over the next five years, will reach 58 million US$ in 2024, from 56 million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Guaifenesin (API) in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Granules
Synthokem Labs
Haizhou Pharma
Yuan Cheng Group
Stellar Chemical
Biesterfeld
Seven Star Pharma
Camlin Fine Science
Gennex Lab
Iwaki Seiyaku
Pan Drugs
Delta Synthetic
Smart Pharm

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
98%-99%
>99%

Market Segment by Applications, can be divided into
Pharmaceuticals
Others

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Guaifenesin (API) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Guaifenesin (API), with price, sales, revenue and global market share of Guaifenesin (API) in 2017 and 2018.
Chapter 3, the Guaifenesin (API) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Guaifenesin (API) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Guaifenesin (API) market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Guaifenesin (API) sales channel, distributors, customers, research findings and conclusion, appendix and data source.


Table of Contents

    1 Market Overview

    • 1.1 Guaifenesin (API) Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 98%-99%
      • 1.2.2 >99%
    • 1.3 Market Analysis by Applications
      • 1.3.1 Pharmaceuticals
      • 1.3.2 Others
    • 1.4 Market Analysis by Regions
      • 1.4.1 North America (United States, Canada and Mexico)
        • 1.4.1.1 United States Market States and Outlook (2014-2024)
        • 1.4.1.2 Canada Market States and Outlook (2014-2024)
        • 1.4.1.3 Mexico Market States and Outlook (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
        • 1.4.2.1 Germany Market States and Outlook (2014-2024)
        • 1.4.2.2 France Market States and Outlook (2014-2024)
        • 1.4.2.3 UK Market States and Outlook (2014-2024)
        • 1.4.2.4 Russia Market States and Outlook (2014-2024)
        • 1.4.2.5 Italy Market States and Outlook (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        • 1.4.3.1 China Market States and Outlook (2014-2024)
        • 1.4.3.2 Japan Market States and Outlook (2014-2024)
        • 1.4.3.3 Korea Market States and Outlook (2014-2024)
        • 1.4.3.4 India Market States and Outlook (2014-2024)
        • 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
      • 1.4.4 South America, Middle East and Africa
        • 1.4.4.1 Brazil Market States and Outlook (2014-2024)
        • 1.4.4.2 Egypt Market States and Outlook (2014-2024)
        • 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
        • 1.4.4.4 South Africa Market States and Outlook (2014-2024)
        • 1.4.4.5 Turkey Market States and Outlook (2014-2024)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 Granules
      • 2.1.1 Business Overview
      • 2.1.2 Guaifenesin (API) Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Granules Guaifenesin (API) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Synthokem Labs
      • 2.2.1 Business Overview
      • 2.2.2 Guaifenesin (API) Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Synthokem Labs Guaifenesin (API) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Haizhou Pharma
      • 2.3.1 Business Overview
      • 2.3.2 Guaifenesin (API) Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Haizhou Pharma Guaifenesin (API) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Yuan Cheng Group
      • 2.4.1 Business Overview
      • 2.4.2 Guaifenesin (API) Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Yuan Cheng Group Guaifenesin (API) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Stellar Chemical
      • 2.5.1 Business Overview
      • 2.5.2 Guaifenesin (API) Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Stellar Chemical Guaifenesin (API) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 Biesterfeld
      • 2.6.1 Business Overview
      • 2.6.2 Guaifenesin (API) Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Biesterfeld Guaifenesin (API) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 Seven Star Pharma
      • 2.7.1 Business Overview
      • 2.7.2 Guaifenesin (API) Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Seven Star Pharma Guaifenesin (API) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 Camlin Fine Science
      • 2.8.1 Business Overview
      • 2.8.2 Guaifenesin (API) Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 Camlin Fine Science Guaifenesin (API) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.9 Gennex Lab
      • 2.9.1 Business Overview
      • 2.9.2 Guaifenesin (API) Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 Gennex Lab Guaifenesin (API) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.10 Iwaki Seiyaku
      • 2.10.1 Business Overview
      • 2.10.2 Guaifenesin (API) Type and Applications
        • 2.10.2.1 Product A
        • 2.10.2.2 Product B
      • 2.10.3 Iwaki Seiyaku Guaifenesin (API) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.11 Pan Drugs
      • 2.11.1 Business Overview
      • 2.11.2 Guaifenesin (API) Type and Applications
        • 2.11.2.1 Product A
        • 2.11.2.2 Product B
      • 2.11.3 Pan Drugs Guaifenesin (API) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.12 Delta Synthetic
      • 2.12.1 Business Overview
      • 2.12.2 Guaifenesin (API) Type and Applications
        • 2.12.2.1 Product A
        • 2.12.2.2 Product B
      • 2.12.3 Delta Synthetic Guaifenesin (API) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.13 Smart Pharm
      • 2.13.1 Business Overview
      • 2.13.2 Guaifenesin (API) Type and Applications
        • 2.13.2.1 Product A
        • 2.13.2.2 Product B
      • 2.13.3 Smart Pharm Guaifenesin (API) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Guaifenesin (API) Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

    • 3.1 Global Guaifenesin (API) Sales and Market Share by Manufacturer (2017-2018)
    • 3.2 Global Guaifenesin (API) Revenue and Market Share by Manufacturer (2017-2018)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 Guaifenesin (API) Manufacturer Market Share in 2018
      • 3.3.2 Top 6 Guaifenesin (API) Manufacturer Market Share in 2018
    • 3.4 Market Competition Trend

    4 Global Guaifenesin (API) Market Analysis by Regions

    • 4.1 Global Guaifenesin (API) Sales, Revenue and Market Share by Regions
      • 4.1.1 Global Guaifenesin (API) Sales and Market Share by Regions (2014-2019)
      • 4.1.2 Global Guaifenesin (API) Revenue and Market Share by Regions (2014-2019)
    • 4.2 North America Guaifenesin (API) Sales and Growth Rate (2014-2019)
    • 4.3 Europe Guaifenesin (API) Sales and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Guaifenesin (API) Sales and Growth Rate (2014-2019)
    • 4.5 South America Guaifenesin (API) Sales and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Guaifenesin (API) Sales and Growth Rate (2014-2019)

    5 North America Guaifenesin (API) by Country

    • 5.1 North America Guaifenesin (API) Sales, Revenue and Market Share by Country
      • 5.1.1 North America Guaifenesin (API) Sales and Market Share by Country (2014-2019)
      • 5.1.2 North America Guaifenesin (API) Revenue and Market Share by Country (2014-2019)
    • 5.2 United States Guaifenesin (API) Sales and Growth Rate (2014-2019)
    • 5.3 Canada Guaifenesin (API) Sales and Growth Rate (2014-2019)
    • 5.4 Mexico Guaifenesin (API) Sales and Growth Rate (2014-2019)

    6 Europe Guaifenesin (API) by Country

    • 6.1 Europe Guaifenesin (API) Sales, Revenue and Market Share by Country
      • 6.1.1 Europe Guaifenesin (API) Sales and Market Share by Country (2014-2019)
      • 6.1.2 Europe Guaifenesin (API) Revenue and Market Share by Country (2014-2019)
    • 6.2 Germany Guaifenesin (API) Sales and Growth Rate (2014-2019)
    • 6.3 UK Guaifenesin (API) Sales and Growth Rate (2014-2019)
    • 6.4 France Guaifenesin (API) Sales and Growth Rate (2014-2019)
    • 6.5 Russia Guaifenesin (API) Sales and Growth Rate (2014-2019)
    • 6.6 Italy Guaifenesin (API) Sales and Growth Rate (2014-2019)

    7 Asia-Pacific Guaifenesin (API) by Country

    • 7.1 Asia-Pacific Guaifenesin (API) Sales, Revenue and Market Share by Country
      • 7.1.1 Asia-Pacific Guaifenesin (API) Sales and Market Share by Country (2014-2019)
      • 7.1.2 Asia-Pacific Guaifenesin (API) Revenue and Market Share by Country (2014-2019)
    • 7.2 China Guaifenesin (API) Sales and Growth Rate (2014-2019)
    • 7.3 Japan Guaifenesin (API) Sales and Growth Rate (2014-2019)
    • 7.4 Korea Guaifenesin (API) Sales and Growth Rate (2014-2019)
    • 7.5 India Guaifenesin (API) Sales and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Guaifenesin (API) Sales and Growth Rate (2014-2019)

    8 South America Guaifenesin (API) by Country

    • 8.1 South America Guaifenesin (API) Sales, Revenue and Market Share by Country
      • 8.1.1 South America Guaifenesin (API) Sales and Market Share by Country (2014-2019)
      • 8.1.2 South America Guaifenesin (API) Revenue and Market Share by Country (2014-2019)
    • 8.2 Brazil Guaifenesin (API) Sales and Growth Rate (2014-2019)
    • 8.3 Argentina Guaifenesin (API) Sales and Growth Rate (2014-2019)
    • 8.4 Colombia Guaifenesin (API) Sales and Growth Rate (2014-2019)

    9 Middle East and Africa Guaifenesin (API) by Countries

    • 9.1 Middle East and Africa Guaifenesin (API) Sales, Revenue and Market Share by Country
      • 9.1.1 Middle East and Africa Guaifenesin (API) Sales and Market Share by Country (2014-2019)
      • 9.1.2 Middle East and Africa Guaifenesin (API) Revenue and Market Share by Country (2014-2019)
    • 9.2 Saudi Arabia Guaifenesin (API) Sales and Growth Rate (2014-2019)
    • 9.3 Turkey Guaifenesin (API) Sales and Growth Rate (2014-2019)
    • 9.4 Egypt Guaifenesin (API) Sales and Growth Rate (2014-2019)
    • 9.5 Nigeria Guaifenesin (API) Sales and Growth Rate (2014-2019)
    • 9.6 South Africa Guaifenesin (API) Sales and Growth Rate (2014-2019)

    10 Global Guaifenesin (API) Market Segment by Type

    • 10.1 Global Guaifenesin (API) Sales, Revenue and Market Share by Type (2014-2019)
      • 10.1.1 Global Guaifenesin (API) Sales and Market Share by Type (2014-2019)
      • 10.1.2 Global Guaifenesin (API) Revenue and Market Share by Type (2014-2019)
    • 10.2 98%-99% Sales Growth and Price
      • 10.2.1 Global 98%-99% Sales Growth (2014-2019)
      • 10.2.2 Global 98%-99% Price (2014-2019)
    • 10.3 >99% Sales Growth and Price
      • 10.3.1 Global >99% Sales Growth (2014-2019)
      • 10.3.2 Global >99% Price (2014-2019)

    11 Global Guaifenesin (API) Market Segment by Application

    • 11.1 Global Guaifenesin (API) Sales Market Share by Application (2014-2019)
    • 11.2 Pharmaceuticals Sales Growth (2014-2019)
    • 11.3 Others Sales Growth (2014-2019)

    12 Guaifenesin (API) Market Forecast (2019-2024)

    • 12.1 Global Guaifenesin (API) Sales, Revenue and Growth Rate (2019-2024)
    • 12.2 Guaifenesin (API) Market Forecast by Regions (2019-2024)
      • 12.2.1 North America Guaifenesin (API) Market Forecast (2019-2024)
      • 12.2.2 Europe Guaifenesin (API) Market Forecast (2019-2024)
      • 12.2.3 Asia-Pacific Guaifenesin (API) Market Forecast (2019-2024)
      • 12.2.4 South America Guaifenesin (API) Market Forecast (2019-2024)
      • 12.2.5 Middle East and Africa Guaifenesin (API) Market Forecast (2019-2024)
    • 12.3 Guaifenesin (API) Market Forecast by Type (2019-2024)
      • 12.3.1 Global Guaifenesin (API) Sales Forecast by Type (2019-2024)
      • 12.3.2 Global Guaifenesin (API) Market Share Forecast by Type (2019-2024)
    • 12.4 Guaifenesin (API) Market Forecast by Application (2019-2024)
      • 12.4.1 Global Guaifenesin (API) Sales Forecast by Application (2019-2024)
      • 12.4.2 Global Guaifenesin (API) Market Share Forecast by Application (2019-2024)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
      • 13.1.3 Marketing Channel Future Trend
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Summary:
      Get latest Market Research Reports on Guaifenesin (API) . Industry analysis & Market Report on Guaifenesin (API) is a syndicated market report, published as Global Guaifenesin (API) Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Guaifenesin (API) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      		$3,480.00
      		$5,220.00
      		$6,960.00
      		2,738.76
      		4,108.14
      		5,477.52
      		3,205.08
      		4,807.62
      		6,410.16
      		543,610.80
      		815,416.20
      		1,087,221.60
      		289,988.40
      		434,982.60
      		579,976.80
      Credit card Logo
      Sample Question Discount Download PDF

      Related Reports

      Reason to Buy

      • Trusted By Leaders

        Top executives from leading companies purchase research reports from us. 

      • Shop With Confidence

        We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

      • Customer Centric

        Need assistance related to your research requirements? We are just a phone call or an email away.

      • Personalized Solutions

        Our experienced research specialists are here to help you locate the right reports for your need.

      • Secure Checkout

        Shop without being worried about safety & security of your transactions.
        •

      Request for Sample of this report

      Reports and Markets

      mcafree

      Contact Us

      +1-352-353-0818 (US)

      info@reportsandmarkets.com

      Support

      EMAIL US

      Newsletter

      KEEP UP TO DATE ON ALL THE LATEST REPORTS


      maxmind_logo